Kevin Richard Haas insider trades

Open-market stock purchases and sales by Kevin Richard Haas, Chief Dev and Tech Officer at Veracyte, Inc, from SEC Form 4 filings since Feb 18, 2021.

Recent trades

DateStockTradeValue
Apr 10, 2026VCYT Veracyte, IncBought (not open market)—
Mar 15, 2026MYGN Myriad Genetics IncSold (not open market)$15.6K
Mar 15, 2026MYGN Myriad Genetics IncSold (not open market)$39.1K
Mar 14, 2026MYGN Myriad Genetics IncSold (not open market)$19.4K
Mar 13, 2026MYGN Myriad Genetics IncSold (not open market)$29.9K
Feb 2, 2026MYGN Myriad Genetics IncBought (not open market)—

Companies traded

  • VCYT Veracyte, Inc: other filings, last Apr 10, 2026
  • MYGN Myriad Genetics Inc: other filings, last Mar 15, 2026

Get free alerts when Kevin Richard Haas files a new trade →